Chan Zuckerberg Biohub kick-starts hiring with 47 recruits
pharmafile | February 8, 2017 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CZ Biohub, Mark Zuckerberg, Zuckerberg
The Chan Zuckerberg Biohub, otherwise known as CZ Biohub, has announced its first in-take of recruits. The appointments are predominantly from the faculties of University of California, Berkeley, Stanford University and the University of California, San Francisco. The group incorporates a range of individuals, from senior professors to younger rising stars of the departments. Each individual will receive a five-year appointment while up to $1.5 million in funding will provided to conduct life science research.
“CZ Biohub Investigators share our vision of a planet without disease,” said Joseph DeRisi, co-president of CZ Biohub and professor of biochemistry and biophysics at UC San Francisco. “To realize this vision, we are giving some of the world’s most creative and brilliant researchers access to groundbreaking technology and the freedom to pursue high-risk research. CZ Biohub Investigators will challenge traditional thinking in pursuit of radical discoveries that will make even the most stubborn and deadly diseases treatable.”
It’s a laudable aim and, as a non-profit organisation, they are prepared to release their research findings to the scientific community without charge. The hope is that it will encourage the increased sharing of breakthroughs so that the world can collaborate globally on fighting diseases.